By Emily Mullin A key tool in the early pandemic response, monoclonal antibodies are now ineffective against new variants. Immunocompromised patients are especially at risk.
Source:: Wired
By Emily Mullin A key tool in the early pandemic response, monoclonal antibodies are now ineffective against new variants. Immunocompromised patients are especially at risk.
Source:: Wired
Copyright © 2023 | WordPress Theme by MH Themes